The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy -Part 2
In part two of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss current treatment options for Leber hereditary optic neuropathy (LHON). Show reference
Read the full articleYou might also wanna read
Johnson & Johnson Discontinues JNJ-1887 Gene Therapy Program for Geographic Atrophy
July 16, 2026 — Johnson & Johnson has discontinued development of JNJ-1887, its investigational AAV2-based gene therapy for geographic atrop
One-Time Gene Therapy Restores Vision in 6-Year-Old with Rare Congenital Blindness
Saffie Sandford from Stevenage was diagnosed with Leber's Congenital Amaurosis, (LCA) a mutation in the RPE 65 gene.
goodnewsnetwork.org·26d agoSafety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD)
Conditions : Leber Congenital Amaurosis; Leber Congenital Amaurosis (LCA); LCA5 Interventions : Drug: OPGx-RDH12 Sponsors : Opus Genetics, I
Hematopoietic stem cell gene therapy delivers cell-penetrating frataxin to treat Friedreich's ataxia in preclinical models
Engineered hematopoietic stem cells delivering a secreted, tissue-penetrating frataxin restore mitochondrial function and ameliorate disease
Life Biosciences Conducts First Gene Therapy Trial to Reverse Cellular Aging in Patient with Glaucoma
For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable vision loss. The ris
popularmechanics.com·20d ago
Single CRISPR infusion reduces hereditary angioedema attacks by 87% in phase 3 trial
A single intravenous dose of Intellia Therapeutics’ in vivo CRISPR-Cas9 therapy lonvoguran ziclumeran (lonvo-z) reduced monthly hereditary a
crisprmedicinenews.com·26d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.